Company Profiles
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of patients around the world in their fight against cancer, cardiovascular disease, hepatitis C, HIV and rheumatoid arthritis. The Bristol-Myers Squibb Foundation’s philanthropic programs seek to promote health equity and improve the health outcomes among populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in cancer and other diseases. Incyte’s drug discovery activities were initiated in 2002 on the belief that investments in innovation create value. Incyte remains committed to the rigorous pursuit of R&D excellence to improve the lives of patients, make a difference in health care, and build sustainable value for its stakeholders.
The Company strives to discover and develop first-in-class and best-in-class medicine and is advancing a diverse portfolio of large and small molecules comprised of 18 development candidates against 14 different molecular targets.
Headquartered in Wilmington, Delaware, Incyte Corporation has offices in Switzerland, nine other European countries and Japan. For more information, visit www.incyte.com. Follow @Incyte on Twitter at .